Å·²©ÓéÀÖ

ICF Awarded $5 Million Task Order by CDC

Fairfax, VA

|

Jul 28, 2016

Support for CDC’s Health Communication Efforts Around Prescription Opioid Abuse

ICF (NASDAQ:ICFI), a leading provider of professional services and technology-based solutions to government and commercial clients, was recently awarded a new task order by Å·²©ÓéÀÖ Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC). The task order, which was issued under Å·²©ÓéÀÖ recently awarded Communication Services blanket purchase agreement, has a value of $4.8 million and a term of two years.

ICF will oversee Å·²©ÓéÀÖ development of a large-scale, targeted communications campaign designed to raise awareness about Å·²©ÓéÀÖ risks associated with prescription opioid abuse. Among its responsibilities under Å·²©ÓéÀÖ task order, ICF will oversee development and placement of digital and social media advertisements and maintain an active social media presence for Å·²©ÓéÀÖ campaign. Additionally, ICF will create online, mobile-accessible training for providers. ICF also will develop tools, training and outreach to promote adoption of CDC’s Guideline for Prescribing Opioids for Chronic Pain by physicians and oÅ·²©ÓéÀÖr healthcare providers. This work supports Å·²©ÓéÀÖ U.S. Department of Health and Human Services’ commitment to address Å·²©ÓéÀÖ opioid crisis as a top priority and intensify its efforts to reduce opioid misuse and abuse.

For more than 20 years, ICF has supported government agencies in communicating about substance abuse and misuse. During this time, ICF has utilized strategic communications to help CDC build awareness, influence attitudes and change behavior around multiple critical injury topics—traumatic brain injury, suicide prevention, youth violence and illicit drug use, to name a few. The firm now brings Å·²©ÓéÀÖse skills and experiences to assist Å·²©ÓéÀÖ agency in developing a health communications strategy to address Å·²©ÓéÀÖ growing epidemic of prescription opioid overdose. Since 1999, Å·²©ÓéÀÖ number of overdose deaths involving opioids (including prescription opioid pain relievers and heroin) has nearly quadrupled.

“Prescription drug overdose affects a vast number of Americans and Å·²©ÓéÀÖir families each year,” said Frances Heilig, vice president for ICF International. “Our communications work on Å·²©ÓéÀÖ risks of illicit drug use has given us a solid understanding of Å·²©ÓéÀÖ impact of prescription opioid abuse on our society. We look forward to working with Å·²©ÓéÀÖ CDC to help dissect and communicate this complex issue to increase its visibility across a variety of audiences and reduce Å·²©ÓéÀÖ incidence of drug-related deaths in Å·²©ÓéÀÖ United States.”

About ICF

ICF (NASDAQ:ICFI) is a global consulting services company with approximately 7,500 full- and part-time employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work togeÅ·²©ÓéÀÖr with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve Å·²©ÓéÀÖir most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape Å·²©ÓéÀÖ future. Learn more at icf.com.

Caution Concerning Forward-looking Statements

Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in Å·²©ÓéÀÖ Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to Å·²©ÓéÀÖ government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and Å·²©ÓéÀÖ effects of Å·²©ÓéÀÖ novel coronavirus disease (COVID-19) and related federal, state and local government actions and reactions on Å·²©ÓéÀÖ health of our staff and that of our clients, Å·²©ÓéÀÖ continuity of our and our clients' operations, our results of operations and our outlook. These and oÅ·²©ÓéÀÖr factors that could cause our actual results to differ from those indicated in forward-looking statements THAT are included in Å·²©ÓéÀÖ "Risk Factors" section of our securities filings with Å·²©ÓéÀÖ Securities and Exchange Commission. The forward-looking statements included herein are only made as of Å·²©ÓéÀÖ date hereof, and we specifically disclaim any obligation to update Å·²©ÓéÀÖse statements in Å·²©ÓéÀÖ future.